CUBE vs PMCB
CubeSmart (CUBE) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the CUBE and PMCB stock pages for the full models.
Not investment advice.